TaiMed Biologics Statistics

Total Valuation

TPEX:4147 has a market cap or net worth of TWD 25.67 billion. The enterprise value is 24.51 billion.

Market Cap	25.67B
Enterprise Value	24.51B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4147 has 273.12 million shares outstanding. The number of shares has increased by 7.93% in one year.

Current Share Class	273.12M
Shares Outstanding	273.12M
Shares Change (YoY)	+7.93%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	6.07%
Float	185.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.26
PB Ratio	6.41
P/TBV Ratio	7.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-115.85
EV / Sales	40.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-65.83

Financial Position

The company has a current ratio of 24.12, with a Debt / Equity ratio of 0.13.

Current Ratio	24.12
Quick Ratio	13.01
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-1.38
Interest Coverage	-21.36

Financial Efficiency

Return on equity (ROE) is -5.15% and return on invested capital (ROIC) is -3.28%.

Return on Equity (ROE)	-5.15%
Return on Assets (ROA)	-2.98%
Return on Invested Capital (ROIC)	-3.28%
Return on Capital Employed (ROCE)	-5.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	0.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.91% in the last 52 weeks. The beta is -0.05, so TPEX:4147's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+2.91%
50-Day Moving Average	82.67
200-Day Moving Average	84.58
Relative Strength Index (RSI)	62.83
Average Volume (20 Days)	1,171,819

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4147 had revenue of TWD 607.46 million and -211.60 million in losses. Loss per share was -0.77.

Revenue	607.46M
Gross Profit	234.30M
Operating Income	-248.55M
Pretax Income	-211.60M
Net Income	-211.60M
EBITDA	-100.83M
EBIT	-248.55M
Loss Per Share	-0.77

Full Income Statement

Balance Sheet

The company has 1.68 billion in cash and 515.31 million in debt, giving a net cash position of 1.16 billion or 4.25 per share.

Cash & Cash Equivalents	1.68B
Total Debt	515.31M
Net Cash	1.16B
Net Cash Per Share	4.25
Equity (Book Value)	4.01B
Book Value Per Share	14.67
Working Capital	3.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -361.18 million and capital expenditures -11.18 million, giving a free cash flow of -372.36 million.

Operating Cash Flow	-361.18M
Capital Expenditures	-11.18M
Free Cash Flow	-372.36M
FCF Per Share	-1.36

Full Cash Flow Statement

Margins

Gross margin is 38.57%, with operating and profit margins of -40.92% and -34.83%.

Gross Margin	38.57%
Operating Margin	-40.92%
Pretax Margin	-34.83%
Profit Margin	-34.83%
EBITDA Margin	-16.60%
EBIT Margin	-40.92%
FCF Margin	n/a

Dividends & Yields

TPEX:4147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.93%
Shareholder Yield	n/a
Earnings Yield	-0.82%
FCF Yield	-1.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4147 has an Altman Z-Score of 15.57 and a Piotroski F-Score of 2.

Altman Z-Score	15.57
Piotroski F-Score	2